China SXT Pharmaceuticals, Inc. (SXTC) NASDAQ

Currency In USD

AD

Valuation

Market Cap91.34M
Enterprise Value64.29M
P/E Ratio-0.23
PEG Ratio0
Price/Sales Ratio0.41
Price/Book Ratio0.04
Enterprise/Revenue-10.26
Enterprise/EBITDA3.11

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-2.91
Operating Margin-3.37
AD

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.31

Income Statement

Revenue1.07M
Revenue/Share4.33
Gross Profit183,282
EBITDA-6.98M
Net Income-6.21M
Diluted EPS-9.13

Balance Sheet

Total Cash28.18M
Total Cash/Share48.1
Total Debt1.12M
Total Debt/Equity0.04
Current Ratio7.93
Book Value Per Share50.71

Price History

52-Week Change-99.99
52-Week High83,760
52-Week Low1.78
Moving Average 50 Days65.88
Moving Average 200 Days3,132.7

Statistics

Average Volume1.06M
Shares Outstanding533,975
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:80
Last Split DateAugust 10, 2026
AD